Merck & Co., Inc.
MRK
Hisse Senetlerindeki Sıralama
#40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Hisse Fiyatı
$145.90
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$359.96B
Değişim (1 gün)
0.16%
Değişim (1 yıl)
72.07%
Ülke
US
Ticaret Merck & Co., Inc. (MRK)
Kategori
Healthcare
Merck & Co., Inc. (MRK) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 16.65%
Merck & Co., Inc. şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 16.65%'dir. 2024 yılı sonunda şirketin faaliyet marjı 31.51% idi.
Merck & Co., Inc. için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 16.65% | -59.58% |
| 2025 | 41.19% | 30.72% |
| 2024 | 31.51% | 541.75% |
| 2023 | 4.91% | -84.08% |
| 2022 | 30.84% | 13.80% |
| 2021 | 27.10% | 102.84% |
| 2020 | 13.36% | -34.06% |
| 2019 | 20.26% | -4.07% |
| 2018 | 21.12% | 24.68% |
| 2017 | 16.94% | 22.66% |
| 2016 | 13.81% | -27.73% |
| 2015 | 19.11% | 20.80% |
| 2014 | 15.82% | -9.13% |
| 2013 | 17.41% | -16.70% |
| 2012 | 20.90% | 11.88% |
| 2011 | 18.68% | 155.89% |
| 2010 | 7.30% | -50.20% |
| 2009 | 14.66% | -42.53% |
| 2008 | 25.51% | 9.86% |
| 2007 | 23.22% | 42.54% |
| 2006 | 16.29% | -38.81% |
| 2005 | 26.62% | -9.52% |
| 2004 | 29.42% | -22.80% |
| 2003 | 38.11% | -10.08% |
| 2002 | 42.38% | -3.18% |
| 2001 | 43.77% | 94.36% |
| 2000 | 22.52% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 49.72% | -97.01% |
US
|
|
| 25.70% | -98.46% |
US
|
|
| 29.32% | -98.24% |
US
|
|
| 26.59% | -98.40% |
CH
|
|
| 31.24% | -98.12% |
CH
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.